Using real world data in drug discovery

Medicines Discovery Catapult

Our CEO, Chris Molloy and our Precision Medicine Lead, James Peach, spoke to PharmaTimes about humanising discovery and real world evidence and improving access for SMEs to the NHS Ecosystem.

“The rate of creation of real world healthcare data has not been matched by a similar rate of its use in research. However, in the UK, the NHS is uniquely capable of collecting and making available high-quality data at a population scale. It has made great strides through the NIHR Health Informatics Collaborative, NIHR BioResource and NHS Digital and the formation of Health Data Research UK. The NHS is clearly committed to the best use of health data, but there is an opportunity to leverage this more widely.”

Read the full article at PharmaTimes online.